Encouraging and inspiring the next generation of scientists is at the heart of our Scientist for a Day program. We're thrilled to share a snapshot of our recent intern, Josie, shadowing our team, gaining hands-on experience, and igniting a passion for science. 🔬 #LifeAtNeo #NeoGenomics #Laboratory #STEM #STEMEducation #FutureLeaders #InspirationActivated #FutureScientists
NeoGenomics Laboratories
Hospitals and Health Care
Fort Myers, Florida 31,818 followers
One Lab. Vital Answers.
About us
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company’s Advanced Diagnostics Division serves pharmaceutical clients in clinical trials and drug development. NeoGenomics is committed to connecting patients with life altering therapies and trials. We believe that, together, with our partners, we can help patients with cancer today and the next person diagnosed tomorrow. In carrying out these commitments, NeoGenomics adheres to relevant data protection laws, provides transparency and choice to patients regarding the handling and use of their data through our Notice of Privacy Practices, and has invested in leading technologies to secure the data we maintain. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida; Aliso Viejo and San Diego, California; Research Triangle Park, North Carolina; and Houston, Texas; and a CAP accredited full-service, sample-processing laboratory in Cambridge, United Kingdom. NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and a pharmaceutical firm in Europe.
- Website
-
http://neogenomics.com
External link for NeoGenomics Laboratories
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Fort Myers, Florida
- Type
- Public Company
- Founded
- 2002
- Specialties
- Cytogenetics, Flow Cytometry, Fluorescence In Situ Hybridization (FISH), Molecular Genetics, Immunohistochemistry, Pharma Research Services, Molecular Oncology & Pathology, and Next-Gen Sequencing (NGS)
Locations
-
Primary
9490 NeoGenomics Way
Fort Myers, Florida 33912, US
Employees at NeoGenomics Laboratories
Updates
-
Premier Breakthroughs 24 just wrapped up in National Harbor, Maryland. If we didn’t get to meet you at this event, learn more about our oncology solutions online: https://lnkd.in/gJH7swsP Thank you!
-
-
We had the pleasure of welcoming some bright young minds recently to our laboratory in Fort Myers, Florida! It was inspiring to see their curiosity and excitement as they toured the lab. #NeoGenomics #Laboratory #STEM #STEMEducation #FutureLeaders
-
-
Premier Breakthroughs 24 is an event centered around advancing the full spectrum of healthcare objectives. We’re proud to support this focus with education and resources about oncology solutions that provide the right tests at the right time. If you’re attending, we invite you to come see us at booth #1600.
-
-
We believe that patient care isn't just done within the lab, and we're very passionate about ways we can support patients. At the #NeoGenomics HQ in Fort Myers, Florida, we assembled care packages full of essentials for cancer patients. We were thrilled to have Lee Health visit us and collect packages for cancer patients at #LeeHealth. We're proud to support the community and contribute to the care and comfort of those in need. #SupportCancerPatients #CommunitySupport #OncologyCare #CancerCare
-
-
This year, NeoGenomics signed the Working with Cancer Pledge. By taking the pledge, NeoGenomics demonstrates its commitment to supporting team members living with or caring for a loved one with cancer. To read the full press release, please visit: https://lnkd.in/gdUsd63s #NeoGenomics #WorkingWithCancer #Oncology #PatientCare . . . 1: British Journal of Cancer and International Agency for Research on Cancer (IARC) - Est number of new cases. all cancers, sexes, ages (2020 2: National Cancer Institute, https://lnkd.in/d5aKa4X 3: Publicis Custom Research
-
-
#NeoGenomics Laboratories is partnered with ImmunoGen, Inc. on a FOLR1 testing program to provide testing for folate receptor alpha (FRα), an actionable biomarker in ovarian cancer, to eligible patients. This testing program was designed to help reduce barriers to IHC testing for novel biomarkers and aid oncologists in making informed treatment decisions for their ovarian cancer patients. Testing for FRα expression is performed using the FDA-approved immunohistochemistry (IHC) companion diagnostic (CDx)—VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. This CDx may indicate eligibility for treatment with the associated biomarker-driven therapy. To learn more about this program, the patient eligibility criteria, and to download the test requisition form, please visit: https://lnkd.in/gNxygjTB #OvarianCancer #CancerTesting #Oncology
-
-
The Emergence of Multi-modal Real-world data: The power of Clinico-Genomic data versus traditional RWD Sources is a new #whitepaper that explores crucial and emerging topics, such as: • Why biomarker and genomic data matters for life science • How these data sources unlock what’s been missing from traditional RWD sources • How these newly created longitudinal data sets support drug development from discovery to trial to post-market • Why longitudinal data matters for developing targeted treatments for rare or complex conditions such as multiple myeloma • How tokenization allows for better integration of disparate data sources and meets the scrutiny of peer review and regulatory approval Visit us online to read this whitepaper: https://lnkd.in/gRYNims7 #NeoGenomics #RWD #Oncology